[2] The Phase 3a REDEFINE 2 trial then tested once-weekly CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) against placebo in 1,206 adults with obesity and type 2 diabetes over 68 weeks, reporting a mean bodyweight change of 13.7% versus 3.4% for placebo
Consider a quick check-in with the team at Tonum Nutrition Services if you want clinician reassurance after your injection
Evolution of Insulin: From Human to Analog
This selective senolytic action clears the aged, pro-inflammatory cells that drive tissue dysfunction with aging
The safety profile of GHK-Cu is well-established given its endogenous origin
Why It Works: Stimulates T-cell differentiation and maturation, boosting CD4+ T-cell function and cell-mediated immunity Activates natural killer cells and dendritic cells and induces cytokine signaling (including TLR-9/TLR-2 pathways), strengthening antiviral and antitumor defenses and supporting immune-mediated tissue recovery Older in vitro and animal-model research found T1 also stimulated endothelial cell migration and angiogenesis and accelerated wound closure in a rodent punch-wound model, though this evidence predates modern clinical trials and has not been confirmed in humans Best For: Immune-mediated healing, including recovery from chronic infections, post-surgical immune support, and general immune resilience during tissue repair